{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:49:02Z","timestamp":1791830942760,"version":"4.3.4"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA225716"],"award-info":[{"award-number":["CA225716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA225716-03S1"],"award-info":[{"award-number":["CA225716-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA225716-03S1"],"award-info":[{"award-number":["CA225716-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA254112"],"award-info":[{"award-number":["CA254112"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD023402"],"award-info":[{"award-number":["S10OD023402"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD032141"],"award-info":[{"award-number":["S10OD032141"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA047904"],"award-info":[{"award-number":["CA047904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The fatty acid synthesis pathway is a valid target for the prevention of prostate cancer. However, a clinical-grade inhibitor of fatty acid synthesis is still lacking. This bench-to-bedside study was undertaken to determine the feasibility of fatty acid synthesis inhibition using broccoli constituent sulforaphane (SFN) and its clinical-grade formulation BroccoMax (BMAX). Oral administration of SFN to Hi-Myc mice resulted in the inhibition of prostate adenocarcinoma burden by about 61% that was accompanied by a significant decrease in prostate tumor levels of c-Myc and proliferating cell nuclear antigen proteins and increased apoptosis. Expression of acetyl-CoA carboxylase 1 (ACC1) and fatty acid synthase (FASN) was lower by about 46% and 31%, respectively, in the prostate tumor of SFN-treated mice when compared with that of control mice (P &amp;lt; 0.001). Plasma levels of total free fatty acids (TFFA), cholesterol, and total phospholipids were decreased significantly following SFN treatment. In a double-blind clinical trial, patients with histologically confirmed prostate cancer were randomized to the BMAX (n = 19) or placebo (PBO) group (n = 22). Patients were treated with four capsules of BMAX or four capsules of matching PBO orally two times daily after breakfast and dinner for 4 weeks. Prostate tumor expression of c-Myc, ACC1, FASN, and Ki-67 proteins was significantly lower in the BMAX arm when compared with the PBO group. However, the serum or prostate tumor level of acetyl-CoA or TFFA was not decreased by BMAX treatment. A longer duration treatment with BMAX in patients with early-stage prostate cancer may be necessary to lower the circulating or prostate tumor level of TFFA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>Fatty acid synthesis is a valid target for the prevention of human prostate cancer. In this study, we determined the feasibility of fatty acid synthesis inhibition using SFN in a mouse model and BMAX, its clinical-grade formulation, in prostatectomy patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-25-0488","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:17:03Z","timestamp":1772018223000},"page":"281-292","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bench-to-Bedside Evaluation of Sulforaphane\/BroccoMax on Fatty Acid Synthesis in Prostate Cancer"],"prefix":"10.1158","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3197-4575","authenticated-orcid":false,"given":"Eun-Ryeong","family":"Hahm","sequence":"first","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-0764","authenticated-orcid":false,"given":"Bruce L.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"2Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-4373","authenticated-orcid":false,"given":"Krishna B.","family":"Singh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 3 UPMC Hillman Cancer Center, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-613X","authenticated-orcid":false,"given":"Su-Hyeong","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 3 UPMC Hillman Cancer Center, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-7914","authenticated-orcid":false,"given":"Rahul A.","family":"Parikh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/036c9yv20","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas University Medical Center 4 Department of Medical Oncology, , Kansas City, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8675-5014","authenticated-orcid":false,"given":"Daniel P.","family":"Normolle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 5 Department of Biostatistics, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-6112","authenticated-orcid":false,"given":"Rajiv","family":"Dhir","sequence":"additional","affiliation":[{"name":"6Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-4166","authenticated-orcid":false,"given":"Tunde","family":"Oyebamiji","sequence":"additional","affiliation":[{"name":"2Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-0817","authenticated-orcid":false,"given":"Xuejiao","family":"Sun","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 7 Biomedical Optical Imaging Laboratory, Departments of Medicine and Bioengineering, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6388-9674","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 7 Biomedical Optical Imaging Laboratory, Departments of Medicine and Bioengineering, , Pittsburgh, Pennsylvania."},{"id":[{"id":"https:\/\/ror.org\/047426m28","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Illinois Urbana-Champaign 8 Department of Bioengineering, Department of Electrical and Computer Engineering, Grainger College of Engineering, Beckman Institute for Advanced Science and Technology, Cancer Center at Illinois, , Urbana, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-7388","authenticated-orcid":false,"given":"Leonard J.","family":"Appleman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 3 UPMC Hillman Cancer Center, , Pittsburgh, Pennsylvania."},{"name":"9Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9083-6933","authenticated-orcid":false,"given":"Stacy L.","family":"Gelhaus","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3733-144X","authenticated-orcid":false,"given":"Shivendra V.","family":"Singh","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania."},{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 3 UPMC Hillman Cancer Center, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026050103102450400_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026050103102450400_bib2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev"},{"key":"2026050103102450400_bib3","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026050103102450400_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2026050103102450400_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/nu14040851","article-title":"Lipid metabolism and epigenetics crosstalk in prostate cancer","volume":"14","author":"Pardo","year":"2022","journal-title":"Nutrients"},{"key":"2026050103102450400_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/ijo.2023.5522","article-title":"New insights into lipid metabolism and prostate cancer (Review)","volume":"62","author":"Zhang","year":"2023","journal-title":"Int J Oncol"},{"key":"2026050103102450400_bib7","first-page":"707","article-title":"Fatty acid synthase expression defines distinct molecular signatures in prostate cancer","volume":"1","author":"Rossi","year":"2003","journal-title":"Mol Cancer Res"},{"key":"2026050103102450400_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41388-020-01553-z","article-title":"A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer","volume":"40","author":"Singh","year":"2021","journal-title":"Oncogene"},{"key":"2026050103102450400_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by Cucurbitacin B: a bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao","year":"2014","journal-title":"Cancer Lett"},{"key":"2026050103102450400_bib10","doi-asserted-by":"crossref","first-page":"102720","DOI":"10.1016\/j.jbc.2022.102720","article-title":"Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial \u03b2-oxidation in castration-resistant prostate cancer cells","volume":"299","author":"Liu","year":"2023","journal-title":"J Biol Chem"},{"key":"2026050103102450400_bib11","first-page":"3799","article-title":"RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells","volume":"63","author":"De Schrijver","year":"2003","journal-title":"Cancer Res"},{"key":"2026050103102450400_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(96)90218-X","article-title":"Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer","volume":"27","author":"Shurbaji","year":"1996","journal-title":"Hum Pathol"},{"key":"2026050103102450400_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jnci\/djp030","article-title":"Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer","volume":"101","author":"Migita","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026050103102450400_bib14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1093\/aje\/kwt136","article-title":"Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer","volume":"178","author":"Chavarro","year":"2013","journal-title":"Am J Epidemiol"},{"key":"2026050103102450400_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4155\/fmc.12.62","article-title":"Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs","volume":"4","author":"Wang","year":"2012","journal-title":"Future Med Chem"},{"key":"2026050103102450400_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1467-789x.2000.00011.x","article-title":"Orlistat for the treatment of obesity: rapid review and cost-effectiveness model","volume":"1","author":"Foxcroft","year":"2000","journal-title":"Obes Rev"},{"key":"2026050103102450400_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: a critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf"},{"key":"2026050103102450400_bib18","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.18632\/oncotarget.2433","article-title":"The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer","volume":"5","author":"Sadowski","year":"2014","journal-title":"Oncotarget"},{"key":"2026050103102450400_bib19","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026050103102450400_bib20","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II investigation of TVB-2640 (Denifanstat) with bevacizumab in patients with first relapse high-grade astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026050103102450400_bib21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"2026050103102450400_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.11317","article-title":"Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells","volume":"106","author":"Brusselmans","year":"2003","journal-title":"Int J Cancer"},{"key":"2026050103102450400_bib23","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1158\/1535-7163.MCT-19-0046","article-title":"Leelamine is a novel lipogenesis inhibitor in prostate cancer cells in vitro and in vivo","volume":"18","author":"Singh","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2026050103102450400_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/carcin\/bgaa009","article-title":"RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells","volume":"41","author":"Kim","year":"2020","journal-title":"Carcinogenesis"},{"key":"2026050103102450400_bib25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/01635581.2016.1224365","article-title":"Effects of \u03c9-3 fatty acids and catechins on fatty acid synthase in the prostate: a randomized controlled trial","volume":"68","author":"Zhang","year":"2016","journal-title":"Nutr Cancer"},{"key":"2026050103102450400_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/carcin\/bgy051","article-title":"Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism","volume":"39","author":"Singh","year":"2018","journal-title":"Carcinogenesis"},{"key":"2026050103102450400_bib27","doi-asserted-by":"crossref","first-page":"1497566","DOI":"10.3389\/fphys.2025.1497566","article-title":"Glucoraphanin conversion into sulforaphane and related compounds by gut microbiota","volume":"16","author":"Dmytriv","year":"2025","journal-title":"Front Physiol"},{"key":"2026050103102450400_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/djt153","article-title":"Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model","volume":"105","author":"Hahm","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"2026050103102450400_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1158\/1940-6207.CAPR-15-0119","article-title":"Sulforaphane bioavailability and chemopreventive activity in women scheduled for breast biopsy","volume":"8","author":"Atwell","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"2026050103102450400_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jnutbio.2013.10.007","article-title":"Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice","volume":"25","author":"Choi","year":"2014","journal-title":"J Nutr Biochem"},{"key":"2026050103102450400_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1940-6207.CAPR-14-0459","article-title":"Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy","volume":"8","author":"Cipolla","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"2026050103102450400_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s10637-014-0189-z","article-title":"A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer","volume":"33","author":"Alumkal","year":"2015","journal-title":"Invest New Drugs"},{"key":"2026050103102450400_bib33","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/0008-5472.CAN-08-3502","article-title":"Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells","volume":"69","author":"Singh","year":"2009","journal-title":"Cancer Res"},{"key":"2026050103102450400_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-030-32656-2_13","article-title":"The role of Rb in prostate cancer progression","volume":"1210","author":"Burkhart","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2026050103102450400_bib35","doi-asserted-by":"crossref","first-page":"102226","DOI":"10.1016\/j.clgc.2024.102226","article-title":"Evaluation of the prognostic role of TP53 gene mutations in prostate cancer outcome: a systematic review and meta-analysis","volume":"22","author":"Maddah","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"2026050103102450400_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"2026050103102450400_bib37","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/jcb.25541","article-title":"Sulforaphane Inhibits c-Myc-mediated prostate cancer stem-like traits","volume":"117","author":"Vyas","year":"2016","journal-title":"J Cel Biochem"},{"key":"2026050103102450400_bib38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2174\/1389203717666160627071125","article-title":"AMPK regulation of glucose, lipid and protein metabolism: mechanisms and nutritional significance","volume":"18","author":"He","year":"2017","journal-title":"Curr Protein Pept Sci"},{"key":"2026050103102450400_bib39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1159\/000494547","article-title":"Activation of Nrf2 by sulforaphane inhibits high glucose-induced progression of pancreatic cancer via AMPK dependent signaling","volume":"50","author":"Chen","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026050103102450400_bib40","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.gendis.2023.04.022","article-title":"The roles and mechanisms of SREBP1 in cancer development and drug response","volume":"11","author":"He","year":"2023","journal-title":"Genes Dis"},{"key":"2026050103102450400_bib41","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1158\/1535-7163.MCT-09-0104","article-title":"D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells","volume":"8","author":"Kim","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"2026050103102450400_bib42","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.0908908106","article-title":"Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6","volume":"106","author":"Gibbs","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050103102450400_bib43","doi-asserted-by":"crossref","first-page":"e1700665","DOI":"10.1002\/mnfr.201700665","article-title":"Untargeted metabolomic screen reveals changes in human plasma metabolite profiles following consumption of fresh broccoli sprouts","volume":"62","author":"Housley","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"2026050103102450400_bib44","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s11095-011-0500-z","article-title":"Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice","volume":"28","author":"Clarke","year":"2011","journal-title":"Pharm Res"},{"key":"2026050103102450400_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/01635581.2019.1619783","article-title":"Sulforaphane bioavailability and chemopreventive activity in men presenting for biopsy of the prostate gland: a randomized controlled trial","volume":"72","author":"Zhang","year":"2020","journal-title":"Nutr Cancer"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-25-0488\/3742058\/capr-25-0488.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-25-0488\/3748847\/capr-25-0488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/19\/5\/281\/3783983\/capr-25-0488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/19\/5\/281\/3783983\/capr-25-0488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:10:38Z","timestamp":1777619438000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/19\/5\/281\/784329\/Bench-to-Bedside-Evaluation-of-Sulforaphane"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,2,25]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-25-0488","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.32701989","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.32701977","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.32701986","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.32701974","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.32701983","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.32701992","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.8541978","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}